Abstract:BACKGROUND: Epilepsy is one of chronic severe neurological disorders possess to recurring seizures. And now anti-epileptic drugs are only effective in less than one third of epilepsy patients, and biomarkers predicting are not available when the specific antiepileptic drugs treated. Advanced studies have showed that miRNA may be a key in the pathogenesis of epilepsy beginning in the early 2000 years. Several target genes and pathways of miRNA which related to the therapeutic methods to epilepsy.METHOD: We searched PubMed from Jan 1,2000 to Jan 1, 2017, using the terms "epilepsy AND microRNA AND biomarker" and "seizure AND microRNA AND biomarker". We selected articles that featured novel miRNAs in vivo epilepsy models and patients. We then selected the most relevant articles based on a subjective appraisal of their quality and mechanistic insight that could be relevant to epilepsy.RESULTS: Decrease the expression of has-miR134 could be a potential non-invasive biomarker to use in diagnosis for the epilepsy patients for using hsa-miR-134 also be identified to distinguish patients with and without epilepsy. miR-181a show significant downregulation in the acute stage, but up regulation in the chronic stage and in the latent stage there is no changing and how about this phenomenon appearance in different stage still should be discussed in the future. Besides that, miR- 146a can down-regulated in the patients using genome-wide for serum in circulating miRNAs.miR- 124, miR-199a, and miR-128 etc. could be a candidate for the biomarker in future. miR-15a-5p and -194-5p down-regulated in epilepsy patients, in the future, it may be used as a novel biomarker for improve diagnosis.CONCLUSION: These observations give a chance that new development for diagnosis and treatment of epilepsy patients. Advanced technique and miRNA combination may product more effective roles in epilepsy and other disease. These reports will be available to solve the application of miRNAs as biomarkers and novel therapy approaches for epilepsy. In summary, researcher who focus on miRNAs should be understanding of the causes, treatment, and diagnosis of epilepsy. exploration of any of these effects on the efficacy of these drugs is worthwhile.

MicroRNAs dysregulation in epilepsy.

MicroRNA regulation and dysregulation in epilepsy

miR-485's anti-drug resistant epilepsy effects by regulating SV2A/PSD-95 and targeting ABCC1 and neuronal signaling-transduction proteins in hippocampus of rats

microRNA and Epilepsy

The dysregulation of miRNAs in epilepsy and their regulatory role in inflammation and apoptosis

MicroRNA Dysregulation in Epilepsy: From Pathogenetic Involvement to Diagnostic Biomarker and Therapeutic Agent Development

MicroRNAs as regulators of brain function and targets for treatment of epilepsy

miRNAs: biological and clinical determinants in epilepsy

An Evaluation of the Links Between Microrna, Autophagy, and Epilepsy.

miRNAs in epilepsy: A review from molecular signatures to therapeutic intervention

Dysregulation of miR-146a: a causative factor in epilepsy pathogenesis, diagnosis, and prognosis

MicroRNA-mediated regulation of neurotransmitter receptors in epilepsy: A systematic review

Epimirbase: A Comprehensive Database Of Microrna-Epilepsy Associations

The Challenge of microRNA as a Biomarker of Epilepsy

Profile of miRNA expression in the hippocampus of epileptic mice and the prediction of potential therapeutic targets

The Emerging Role of miRNAs in Epilepsy: From Molecular Signatures to Diagnostic Potential

Microglia in epilepsy

Epigenetic regulation in epilepsy: A novel mechanism and therapeutic strategy for epilepsy

Integrative network analysis of miRNA-mRNA expression profiles during epileptogenesis in rats reveals therapeutic targets after emergence of first spontaneous seizure

Genome-wide circulating microRNA expression profiling indicates biomarkers for epilepsy.

Molecular Chaperones and miRNAs in Epilepsy: Pathogenic Implications and Therapeutic Prospects